Cornerstone Capital Management Holdings’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | $470K | Buy |
41,120
+3,500
| +9% | +$40K | ﹤0.01% | 1018 |
|
2017
Q3 | $459K | Buy |
37,620
+7,100
| +23% | +$86.6K | ﹤0.01% | 1065 |
|
2017
Q2 | $349K | Buy |
30,520
+3,616
| +13% | +$41.3K | ﹤0.01% | 1079 |
|
2017
Q1 | $559K | Buy |
+26,904
| New | +$559K | ﹤0.01% | 1039 |
|
2016
Q4 | – | Sell |
-5,662
| Closed | -$185K | – | 1476 |
|
2016
Q3 | $185K | Buy |
5,662
+2,662
| +89% | +$87K | ﹤0.01% | 1201 |
|
2016
Q2 | $74K | Buy |
+3,000
| New | +$74K | ﹤0.01% | 1292 |
|
2015
Q4 | – | Sell |
-5,400
| Closed | -$176K | – | 1581 |
|
2015
Q3 | $176K | Sell |
5,400
-3,100
| -36% | -$101K | ﹤0.01% | 1243 |
|
2015
Q2 | $450K | Buy |
+8,500
| New | +$450K | ﹤0.01% | 1034 |
|